Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Reduction of Psoriasis Following Liraglutide Therapy in Terms of PASI and DLQI”

1 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 1 of 1 results

Not applicableUnknownNCT01451905
What this trial is testing

GLP-1 Receptors in Normal Skin and Skin From Patients With Psoriasis

Who this might be right for
Reduction of Psoriasis Following Liraglutide Therapy in Terms of PASI and DLQI
University Hospital, Gentofte, Copenhagen 12